chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient states he had reaction to shingles vaccine-Patient got SOB felt  tongue getting thick and bottom lip. Took 2 Benadryl and ss subsided.
Pt recvd series of 3 doses of Engerix-B vax; 3rd dose given 12DEC90; It was determined that pt was not immune to Hep B; Reporter stat pt recvd 2 more injects & is still not serum converted;
pt recv vax 22MAR98 830AM in scholl-no fever;returned home 230PM arm where shot given included hand was black & blue & swollen;ice applied & APAP for pain;clinic advised to go to ER;arm numb & tingly @ 17MAR98;arm bruised;arm aching;
The month due after the injection it was severally heavy to the point patient could not leave her house; have had big changes to menstruation/ It also became irregular and had some bleeding in the middle of cycle; This spontaneous case was reported by a patient and describes the occurrence of HEAVY MENSTRUAL BLEEDING (The month due after the injection it was severally heavy to the point patient could not leave her house) and MENSTRUATION IRREGULAR (have had big changes to menstruation/ It also became irregular and had some bleeding in the middle of cycle) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEAVY MENSTRUAL BLEEDING (The month due after the injection it was severally heavy to the point patient could not leave her house) and MENSTRUATION IRREGULAR (have had big changes to menstruation/ It also became irregular and had some bleeding in the middle of cycle). At the time of the report, HEAVY MENSTRUAL BLEEDING (The month due after the injection it was severally heavy to the point patient could not leave her house) and MENSTRUATION IRREGULAR (have had big changes to menstruation/ It also became irregular and had some bleeding in the middle of cycle) outcome was unknown.            No concomitant medications were reported.   Patient have had big changes to her menstruation. The month due after the injection it was severally heavy to the point patient could not leave her house. It also became irregular and patient had some bleeding in the middle of her cycle. Her booster was moderna and the same thing was happening again.  No treatment medication was provided.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
I got my second pfizer vaccine 0n 1/27/21 at 10 am.  I had no reactions at all after the injection was given.  I waited for 30 minutes and was perfectly fine.  Around 5 pm I started to feel symptoms.  I got the worst aches in my entire body i've ever felt before, along with chills.  I felt extremely hot, I took my temperature and had a fever of 102.3.  I felt dizzy, lightheaded, and nauseas .  My head was throbbing.  I ended up taking 1000mg of tylenol to help reduce the fever, which seemed to really help.  I fell asleep and woke up the next morning drenched in sweat.  My fever was gone, but I still had a horrible headache and threw up from the nausea I was having.  It felt like I had a horrible hangover.
According to mom at 1545 pm emesis, 1615 emesis, 1645 emesis, bath given, approximately 1845 left ear swollen, cheeks flushed, neck red, chest red and splotchy.  Mom requested doc call her at this time.  Approx 1920 doc called and mom reports she was "clearing up" at this time.  She nursed her and the infant then began chewing on a teething ring.  Doc advised mom to keep an eye on her and make sure the adverse event was documented.
3 days after 1st shot,  I had had swollen joint on my right thumb, it lasted for 3 days, then I had keen pain , lasted for a day. No treatment.
Nose bleeds; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nose bleeds) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (Nose bleeds). At the time of the report, EPISTAXIS (Nose bleeds) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication provided.  No treatment medication provided.
UNSPECIFIED SIDE EFFECTS; This spontaneous report received from a health care professional concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 13-APR-2021, the subject experienced unspecified side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified side effects was not reported. This report was non-serious.
This spontaneous report was received from a 26 year old female patient regarding herself. Patient had no pertinent medical history and no drug reactions/allergies. On 19-JAN-201, the patient was vaccinated with the 'last dose' of GARDASIL 120 Y, intramuscularly  (lot# and expiration date was not provided). Concomitant therapy included an unspecified oral contraceptive medication. Two days later, on approximately 21-JAN-2016, after receiving vaccination, the patient started to experience a severe headache/migraine. She also experienced nausea when standing up and would vomit if she stood up too fast. Patient sought medical attention-she visited the urgent care facility on the same day was given anti-inflammatory shots, ibuprofen and an unspecified anti-emetic. Her symptoms continued to 24-JAN-2016, when she had also experienced blurred vision, more vomiting and twitching. Again, on 25-JAN-2016, the patient visited the urgent care facility and received treatment. Urine analysis and blood testing was performed (date of test and results was not provided). Outcome of the adverse events was reported as not recovered. Causality assessment was not provided. No product quality complaint was involved. Additional information has been requested.
Was fine after shot and waiting 15 minutes. Later on in the night around 7:30pm felt nauseas and vomited slightly. Next day felt better but  continued to feel "drained" like I had the cold of flu. Eventually by the 3rd day symptoms had subsided.
She had an allergic reaction or a bad reaction; This is a spontaneous report from a contactable consumer or other non hcp (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced she had an allergic reaction or a bad reaction on an unspecified date. patient was actually calling because she took the Pfizer vaccine for COVID and she had a couple of questions, where she's going to send the medical bills to because she had an allergic reaction or a bad reaction. The outcome for event was unknown.   The lot number for the vaccine, [enter generic Pfizer vaccine name], was not provided and will be requested during follow up
felt dizzy few minutes after receiving vaccine, diaphoretic, like he was going to pass out. states usually passes out when donating blood. came to obs via wheelchair notably diaphoretic. layed down on stretcher, water, apple juice and snack offered. 1220p: bp 105/69 hr 51 rr 20 sats 97% ra. states feeling better after snack, no longer visibly sweating, 1225: bp 120/72 hr 62 rr 20 sats 99% ra. offered additional snacks, states feeling much better. 1235p: sitting up, denies dizziness or other issues, bp 103/69 hr 65 rr 18 sats 99% on ra. standing bp 127/74 hr 70 at 1245p. patient escorted to personal vehicle without issues.
Presented to ED on 9/24 after fall from standing hitting head on edge of table. Noted scalp laceration and right femur fx. 9/25 covid + and  had IM nail of right femur.  Next day had episode of hypotension and severe anemia with hemoglobin of 3.9. Transferred to ICU for crytalloid and product resuscitation and concern for possible hemolysis due to transfusions. Becoming more confused and vomited during NG tube placement with aspiration leading to a hypoxic event and cardiac arrest. Underwent code for approximately 15 minutes. Had severe acute respiratory distress syndrome with increasing pressor requirement and acidosis. Family elected to make patient DNR.
Shoulder was sore, which was not a big deal.  It went away, but then came back and has been more sore and achy the last two days than it was originally.  I've had flu shots before and never had it get sore again later and stay sore.
erthematous, rash on vax site oval shap around 3inch by 7inch along fore arm; no general sxs noted, also mild pruritus
Information has been received from a nurse practitioner concerning a 14 week old male with allergies to milk, peanuts, soy, peas, and chicken, who on 16-OCT-2007, received a 0.5 ml subcutaneous dose in his right thigh of Varivax (Oka/Merck) (lot #658024/0833U). Concomitant vaccination included a 0.5 ml subcutaneous dose in his left thigh of MMR II (lot #655487/0749U). It was reported that 8 hours after vaccination on 16-OCT-2007, he developed symptoms of facial swelling, swollen lips, and hives all over the body. He was treated in the emergency room with adrenalin and steroids plus diphenhydramine (BENADRYL). It was reported that the patient did not develop wheezing. He was not admitted to the hospital. At the time of the report, the reporter felt that the patient was currently recovering, but he continued to take steroids and diphenhydramine (BENADRYL) for the hives that had not yet resolved. A product quality complaint was not reported. No further information was available. The reporter felt that the events were life threatening (facial swelling), disabling, and other important medical events. Additional information has been requested.
Patient came in the next day reporting that the area where they received the vaccination was red, itchy, sensitive, and warm to touch. They went to the doctor's office and were informed that the adverse event was an allergic reaction.
DIZZY; REALLY HOT; This spontaneous report received from a patient concerned a 66 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced dizzy, and really hot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the dizzy and really hot was not reported. This report was non-serious.
Pain in left arm from shoulder to elbow. Can?t lift arm above head or behind back without intense pain.
Patient reported to nurse after receiving first dose of Pfizer that 3-5 minutes later her left side of neck/throat felt tight and tingled. Nurse alerted Doctor and myself to assist patient. We arrived to patient's car in front of garage at 10:55 AM and walked beside car as the husband pulled forward to park. Patient stated she received her vaccine about 10:45 and then as her husband started pulling forward, she told him about her symptoms. Dr. assessed patient and stayed with patient until 11:13AM. Patient left in passenger seat with her husband driving stating that she no longer felt the tightness in her neck or throat.
COVID VACCINE WAS GIVEN TO UNDERAGE PT. PT IS ONLY 17 YRS OLD, TURNS 18 IN MARCH.  VACCINE NOT APPROVED FOR SOMEONE UNDER THE AGE OF 18. NURSING FACILITY WAS NOTIFIED. THEY SAID THEY WOULD NOTIFY PARENTS. PATIENT HAS NO ADVERSE SYSMPTOMS AT THE TIME VACCINE WAS GIVEN. FACILITY SAID THEY WILL MONITOR PT.
I'm reporting a possible error regarding the administration of a Pfizer vaccine. When administering a vaccine to a patient I'm not sure if 0.3 mL or 0.5 mL was drawn up. I realized as I was administering the subsequent shot that I was unsure of the dose, and that I used a syringe normally designated for Moderna/JJ doses for a Pfizer dose. The vial itself was not short any doses, but I am reporting out of an abundance of caution.
mom reports 12SEP evening T104 orally, cried all noc;14SEP again felt bad T104 orally cried all noc & talked crazy, asking for mom when mom already present;mom states did not cry more than 3 hrs straight;
Patient younger than 6months of age administered the inactivated flu vaccine.  unknown reaction. pt left with no symptoms
Developed large local reaction to anthrax vaccine  Erythema Start: 05/2007; Swelling Start: 05/2007; Pain Start: 05/2007
This spontaneous non-valid, social media report as received from a parent refers to a female patient of unknown age. The patient's concurrent conditions, medical history and concomitant medications were not reported. On an unknown date, the patient was vaccinated with GARDASIL (dose, route and site of administration, lot # and expiry date were not reported) for prophylaxis. On an unknown date, the patient got very ill from GARDASIL and did not finish the series. The outcome of the event was unknown. The reporter considered the event to be related to GARDASIL. Additional information is not expected, as there were no contact details provided.
Donor has 1.5" by 1.5" warm swollen red area with no pain denies pain denies any other symptoms has full arm use. Donor reports just now noticing the area to right upper arm 06/20/2019 after donation today. Instructed to call or seek medical attention if area worsens or experiences pain or other symptoms  VIS  reviewed with donor.
Patient was administered ZOSTAVAX vaccine on 12-31-10 when the expiration date was on 12.20.2010. No adverse reaction reported.
Pt. received vaccine on 4/1/13, came in 4/5/13 saying he had severe pain from inj site and appeared to be radiating. Said no swelling of inj site. Stated pain was the worst on 4/4/13 and has subsided now.
This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 61-year-old male patient who received SHINGRIX for prophylaxis. The patient's past medical history included chickenpox (as a child). Concomitant products included medication unknown (Blood Pressure Medication). On 27th September 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In September 2018, less than a week after receiving SHINGRIX, the patient experienced enlargement of lymph nodes. On 27th September 2018, the patient experienced injection site pain. On 28th September 2018, the patient experienced injection site erythema. On 29th September 2018, the patient experienced injection site swelling, injection site lump and injection site inflammation. On an unknown date, the outcome of the injection site swelling was not recovered/not resolved and the outcome of the injection site erythema and injection site pain were recovering/resolving and the outcome of the injection site lump, enlargement of lymph nodes and injection site inflammation were unknown. It was unknown if the reporter considered the injection site swelling, injection site erythema, injection site pain, injection site lump, enlargement of lymph nodes and injection site inflammation to be related to SHINGRIX. Additional details were provided as follows: In the morning, the patient received SHINGRIX in the left arm. The patient experienced redness at the injection site that was approximately two inches in diameter. He also experienced soreness at the injection site. On Saturday night, he experienced a small lump approximately the size of an almond that started to swell and then it was approximately two by two in diameter which he described as the size of a cracked egg. He claimed that the swollen lymph node was on the same side of the injection site. The swelling had increased since Saturday. He described the swelling as inflammation and considerable swelling now that it was four days after the injection.
Vaccination error.  Female 11 yo who received a booster dose of pfizer covid vaccine for 12 yrs and older two months after receiving second dose.  See below for vax dates. PFR 5-11 1st dose:  12/3/21 PFR 5-11 2nd dose:  12/24/21 PFR 12-older booster:  2/16/22
swollen lymph node underneath the arm pit a couple inches in diameter; skin is irritated; redness; lump on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE MASS (lump on arm), LYMPHADENOPATHY (swollen lymph node underneath the arm pit a couple inches in diameter) and SKIN IRRITATION (skin is irritated) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE MASS (lump on arm). On 28-Jan-2021, the patient experienced LYMPHADENOPATHY (swollen lymph node underneath the arm pit a couple inches in diameter) and SKIN IRRITATION (skin is irritated). At the time of the report, VACCINATION SITE ERYTHEMA (redness), VACCINATION SITE MASS (lump on arm), LYMPHADENOPATHY (swollen lymph node underneath the arm pit a couple inches in diameter) and SKIN IRRITATION (skin is irritated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient used Tylenol as treatment medication.
I became Ill; All the minute clinics were out of the shot; This case was reported by a consumer via call center representative and described the occurrence of illness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On 31st January 2020, the patient received the 2nd dose of Shingrix. On an unknown date, less than a year after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced illness and product supply issue. On an unknown date, the outcome of the illness and product supply issue were unknown.   It was unknown if the reporter considered the illness to be related to Shingrix.  Additional details were received as follows: The patient was a reporter. The age at vaccination was not reported. The patient got the shingles vaccination when it was only a 1 dose requirement. Then patient went for the first of the 2 shot vaccination at the end of July 2019. All the clinics were out of the shot but patient was fortunate enough to find a location that had it. They told patient they would call when it was time for the 2nd shot. The patient didn't hear from anyone and assumed they were still very low in stock. The patient managed to speak to the main number for clinic. He told me to call him the da, the patent was going to get the shot and he would be able to tell me where the patient could get one. The patient became Ill in December 2019 and the patient am just feeling better now. I would like to got that 2nd shot today. The patient was asking, if it still ok to get it a few days past the 6th month mark and how do know who had it.
extreme adrenaline rush; shakiness; Panic; brain fog; This is a spontaneous report from a contactable other hcp (patient). A 56-year-old nonpregnant female patient received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, Formulation: solution for injection, Batch/Lot Number en9581, expiration date unspecified), via an unspecified route of administration, administered in Arm Left on 06Feb2021 11:00 (at the age 56-year-old) as DOSE 1, SINGLE for covid-19 immunization at health care facility. Medical history included type 2 diabetes mellitus, autoimmune thyroiditis and Epstein Barr virus positive mucocutaneous ulcer from an unknown date. The patient was taking other medication with the vaccine in two weeks. The patient was not diagnosed with COVID-19 prior to the vaccination. On 06Feb2021 11:15, 15mins post vaccination the patient had an adrenaline rush, shakiness, panic, brain fog. The patient did not receive any treatment for the events. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the events was reported as recovered with lasting effects at the time of report.  Follow-up attempts completed. No further information expected.
headache: started after receiving COVID vaccine (first dose) on 12/27/2021, Was seen on 1/1/2022 with persistent headache.
Information has been received from a licensed practical nurse, for GARDASIL, a Pregnancy Registry product, concerning a female with no pertinent medical history who on 07-JUL-2011 was vaccinated IM with the second dose of 0.5 ml dose of GARDASIL (lot # not reported) and was pregnant. Pregnancy was confirmed by ultrasound. The patient was currently 6 weeks along and her last menstrual cycle was on 22-JUN-2011. The estimated delivery date was 28-MAR-2012. The patient was not experiencing any adverse effects. The patient contacted the physician. No treatment was given to the patient. This is one of several reports received from the same source. Additional information is not expected.
Client's mother reported approximately 10 days after client received her immunizations that a hard, red lump appeared on client's left thigh. Client was afebrile and did not seemed bothered by the lump. Client's parents brought her into her pediatrician who had a culture completed. Culture showed staph per client's mother. Client received oral antibiotic treatment for 10 days as well as an antibiotic cream. Client has had no previous problems with any vaccinations. Received her 2nd flu 0.25 immunization on 12/12/08 and had no reaction per client's mom as of 12/16/08.
6 month old female admitted on 12/23/07 after GTC seizure lasting approximately 1 minute.   Positive post-ictal sombolence.  Patient had a previous GTC seizure after vaccination (1 day approx).  She had 2 seizures, afebrile.  Denies fever or URI, no vomiting, no history of Anec tear.  01/08/2008 VAERS report received with MR attached. Infant admitted 12/5/07  and again 12/23/07 for generalized tonic-clonic seizures, the first occuring after receiving vax on 12/04/07. First episode at home with reported staring, stiffening of arms and legs, jerking of arms and legs and abnormal mouth movement.  2nd episode witnessed by attending as above with dusky change in color.  Pt had no further episodes until 12/23/07 when pt had another tonic-clonic seizure followed by post-ictal period. DX: Seizure Disorder
Arm swelling, stiffness, redness, and warmth. About 6 inches long, covering most of the upper arm that received vaccine. There was a smaller reaction similar around day 3, then the full reaction on day 8.
Tightness in right inner arm, tricep, neck and shoulder when moving, months after injection. Sometimes sharp pain, similar to nerve pain when moving.
Ct. called-c/o excessive underarm sweating after receiving injections. Noticed it more with Twinrix #2 given on 3/30.  States he is not experiencing fever.